R.R. reports compensation for participation on a speaker's bureau for Boehringer Ingelheim. T.M. reports serving as a consultant to Biosense Webster, Boston Scientific, and St. Jude Medical. Some UAB fellowship program projects receive funding from Biotronik, Boston Scientific, CardioFocus, Medtronic, and St. Jude Medical.
Cardiovascular Implantable Electronic Device Implantation with Uninterrupted Dabigatran: Comparison to Uninterrupted Warfarin
Article first published online: 25 JUL 2013
© 2013 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 24, Issue 10, pages 1125–1129, October 2013
How to Cite
JENNINGS, J. M., ROBICHAUX, R., MCELDERRY, H. T., PLUMB, V. J., GUNTER, A., DOPPALAPUDI, H., OSORIO, J., YAMADA, T. and KAY, G. N. (2013), Cardiovascular Implantable Electronic Device Implantation with Uninterrupted Dabigatran: Comparison to Uninterrupted Warfarin. Journal of Cardiovascular Electrophysiology, 24: 1125–1129. doi: 10.1111/jce.12214
- Issue published online: 8 OCT 2013
- Article first published online: 25 JUL 2013
- Accepted manuscript online: 17 JUN 2013 01:39AM EST
- Manuscript Accepted: 17 MAY 2013
- Manuscript Revised: 4 MAY 2013
- Manuscript Received: 11 MAR 2013
This article has been cited by: